L-dopa and L-dopachrome biosynthesis
Pathways in the L-dopa and L-dopachrome biosynthesis SuperPath
| # | Name | Source | Genes |
|---|---|---|---|
| 1 | L-dopa and L-dopachrome biosynthesis | PubChem | |
| 2 | (S)-reticuline biosynthesis | PubChem | |
| 3 | eumelanin biosynthesis | PubChem | |
| 4 | pheomelanin biosynthesis | PubChem | |
| 5 | (S)-reticuline biosynthesis II | PubChem | |
| 6 | L-dopachrome biosynthesis | PubChem |
Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways
| # | Symbol | Description | Category | # Related Pathways |
|---|---|---|---|---|
| 1 | TYR | Tyrosinase | Protein Coding | 6 |
Disorders associated with L-dopa and L-dopachrome biosynthesis SuperPath
according to GeneCards Suite gene sharing
| # | Disorder | Type | Genes | Score |
|---|---|---|---|---|
| 1 | Albinism, oculocutaneous, type ib | Enrichment | TYR | 4.13 |
| 2 | Skin/hair/eye pigmentation, variation in, 3 | Enrichment | TYR | 4.13 |
| 3 | Minimal pigment oculocutaneous albinism type 1 | Enrichment | TYR | 4.13 |
| 4 | Hypopigmentation of the skin | Enrichment | TYR | 4.13 |
| 5 | Albinism, oculocutaneous, type ia | Enrichment | TYR | 3.83 |
| 6 | Melanoma, cutaneous malignant 8 | Enrichment | TYR | 3.83 |
| 7 | Albinism, ocular, type i | Enrichment | TYR | 3.35 |
| 8 | Albinism | Enrichment | TYR | 3.35 |
| 9 | Waardenburg syndrome, type 2e | Enrichment | TYR | 3.29 |
| 10 | Oculocutaneous albinism | Enrichment | TYR | 3.29 |
| 11 | Optic nerve disease | Enrichment | TYR | 3.13 |
| 12 | Myopia | Enrichment | TYR | 2.96 |
| 13 | Skin disease | Enrichment | TYR | 2.79 |
| 14 | Strabismus | Enrichment | TYR | 2.70 |
| 15 | Eye disease | Enrichment | TYR | 2.59 |